We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTN icon
1676
Vail Resorts
MTN
$5.6B
$50.9K ﹤0.01%
383
-1,026
-73% -$151K
BGC icon
1677
BGC Group
BGC
$5.73B
$50.8K ﹤0.01%
5,692
+663
+13% +$5.97K
AXIA.PR
1678
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
$50.3K ﹤0.01%
5,378
AMSF icon
1679
AMERISAFE
AMSF
$573M
$50.2K ﹤0.01%
1,307
-7,562
-85% -$305K
SHV icon
1680
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$49.9K ﹤0.01%
453
XP icon
1681
XP
XP
$8.68B
$49.8K ﹤0.01%
3,045
-145
-5% -$2.55K
LQDT icon
1682
Liquidity Services
LQDT
$1.23B
$49.5K ﹤0.01%
1,632
TIGO icon
1683
Millicom
TIGO
$16B
$49.4K ﹤0.01%
891
BYD icon
1684
Boyd Gaming
BYD
$6.78B
$49.4K ﹤0.01%
579
-95
-14% -$7.83K
OSBC icon
1685
Old Second Bancorp
OSBC
$1.3B
$49.2K ﹤0.01%
2,523
+622
+33% +$11.6K
CART icon
1686
Maplebear
CART
$10.7B
$49K ﹤0.01%
1,089
-11,004
-91% -$450K
FXL icon
1687
First Trust Technology AlphaDEX Fund
FXL
$2.45B
$49K ﹤0.01%
291
DSI icon
1688
iShares MSCI KLD 400 Social ETF
DSI
$5.17B
$49K ﹤0.01%
380
LEGN icon
1689
Legend Biotech
LEGN
$3.68B
$48.9K ﹤0.01%
2,250
-23,291
-91% -$667K
STNG icon
1690
Scorpio Tankers
STNG
$3.94B
$48.8K ﹤0.01%
961
AEO icon
1691
American Eagle Outfitters
AEO
$3.04B
$48.8K ﹤0.01%
1,852
+447
+32% +$8.83K
IONS icon
1692
Ionis Pharmaceuticals
IONS
$9.14B
$48.7K ﹤0.01%
616
NRC icon
1693
NRC Health Common Stock
NRC
$503M
$48.5K ﹤0.01%
2,583
+1,962
+316% +$29.6K
FIZZ icon
1694
National Beverage
FIZZ
$3.05B
$48.5K ﹤0.01%
1,520
-147
-9% -$5.05K
RVTY icon
1695
Revvity
RVTY
$12.4B
$48.5K ﹤0.01%
501
-11
-2% -$1.06K
FMC icon
1696
FMC
FMC
$1.37B
$48.2K ﹤0.01%
3,472
-1,990
-36% -$37.9K
ARCB icon
1697
ArcBest
ARCB
$3.33B
$48.2K ﹤0.01%
650
+64
+11% +$4.55K
BB icon
1698
BlackBerry
BB
$4.74B
$48.2K ﹤0.01%
12,721
OI icon
1699
O-I Glass
OI
$1.39B
$48.1K ﹤0.01%
3,259
-295
-8% -$3.9K
KE
1700
Kimball Electronics
KE
$593M
$48K ﹤0.01%
1,726

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.